Administration of progesterone on the day of oocyte retrieval to reverse accumulation of fluid in the endometrial cavity during assisted reproductive techniques
article
OA: gold
CC0
Abstract
OBJECTIVE: To determine whether administration of progesterone on the day of oocyte retrieval may reverse accumulation of fluid in the endometrial cavity. METHODS: A total of 50 patients who underwent assisted reproductive technology (ART) cycles with endometrial cavity fluid (ECF) observed by ultrasound at the time of oocyte retrieval were included. Upon the identification of ECF, vaginal administration of natural progesterone was started. Two days later, the endometrial cavity was re-evaluated, and embryo transfer was performed in the absence of ECF. RESULTS: ECF was absent two days after administration of vaginal progesterone in 47 of the 50 patients (94%). ECF persisted in 3 of the 50 patients (6%). The clinical pregnancy rate per transfer was 34.0%, and the implantation rate was 21.6%. CONCLUSION: Our data suggest that, in the presence of ECF, administration of intravaginal progesterone in ART cycles must be initiated on the day of follicle aspiration to reverse ECF and to avoid the deleterious effects of fluid on the blastocyst-endometrial interaction.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (23)
- Angiogenesis and Endometriosis via openalex
- W793947 via openalex
- W114880010 via openalex
- W308339578 via openalex
- doi:10.1093/humrep/12.12.2816 via openalex
- W4285719527 via openalex
- W6677549387 via openalex
- doi:10.1186/1477-7827-8-46 via openalex
- doi:10.1093/oxfordjournals.humrep.a137611 via openalex
- doi:10.1023/a:1015785431828 via openalex
- doi:10.1089/neu.2013.3162 via openalex
- doi:10.1093/humrep/16.12.2610 via openalex
- doi:10.1007/s00018-008-8441-3 via openalex
- doi:10.1016/j.rbmo.2013.05.014 via openalex
- doi:10.1097/gco.0b013e3283468b94 via openalex
- doi:10.2174/187152731131200120 via openalex
- doi:10.1186/1745-6215-13-118 via openalex
- doi:10.1023/b:jarg.0000013653.54830.2c via openalex
- doi:10.1093/ajcp/85.4.419 via openalex
- doi:10.1210/endo.140.10.7070 via openalex
- doi:10.1016/j.rbmo.2013.10.022 via openalex
- doi:10.1093/humrep/deh737 via openalex
- doi:10.1210/en.140.10.4809 via openalex
Source provenance
- europepmc
- last seen: 2026-06-16T06:07:01.518242+00:00
- openalex
- last seen: 2026-05-11T06:40:38.933960+00:00
- pubmed
- last seen: 2026-05-13T22:18:04.362919+00:00
License: CC0
· commercial use OK